Cargando…
Margin Accentuation Irreversible Electroporation in Stage III Pancreatic Cancer: A Systematic Review
SIMPLE SUMMARY: This literature review shows preliminary evidence to suggest that electroporation, the use of electricity to cause the death of cells around the tumour, may be associated with an improved survival and complete resection rates following pancreatic surgery for higher stage pancreatic c...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268790/ https://www.ncbi.nlm.nih.gov/pubmed/34199031 http://dx.doi.org/10.3390/cancers13133212 |
_version_ | 1783720434450038784 |
---|---|
author | Ratnayake, Bathiya Al-Leswas, Dhya Mohammadi-Zaniani, Ghazaleh Littler, Peter Sen, Gourab Manas, Derek Pandanaboyana, Sanjay |
author_facet | Ratnayake, Bathiya Al-Leswas, Dhya Mohammadi-Zaniani, Ghazaleh Littler, Peter Sen, Gourab Manas, Derek Pandanaboyana, Sanjay |
author_sort | Ratnayake, Bathiya |
collection | PubMed |
description | SIMPLE SUMMARY: This literature review shows preliminary evidence to suggest that electroporation, the use of electricity to cause the death of cells around the tumour, may be associated with an improved survival and complete resection rates following pancreatic surgery for higher stage pancreatic cancer. However, one in five patients have a complication from the procedure that alters their normal course in hospital. Moreover, the number of patients who underwent this technique is small and further data is needed to support the preliminary evidence. The results therefore should be interpreted with caution. ABSTRACT: The present systematic review aimed to summarise the available evidence on indications and oncological outcomes after MA IRE for stage III pancreatic cancer (PC). A literature search was performed in the Pubmed, MEDLINE, EMBASE, SCOPUS databases using the PRISMA framework to identify all MA IRE studies. Nine studies with 235 locally advanced (LA) (82%, 192/235) or Borderline resectable (BR) PC (18%, 43/235) patients undergoing MA IRE pancreatic resection were included. Patients were mostly male (56%) with a weighted-mean age of 61 years (95% CI: 58–64). Pancreatoduodenectomy was performed in 51% (120/235) and distal pancreatectomy in 49% (115/235). R0 resection rate was 73% (77/105). Clavien Dindo grade 3–5 postoperative complications occurred in 19% (36/187). Follow-up intervals ranged from 3 to 29 months. Local and systematic recurrences were noted in 8 and 43 patients, respectively. The weighted-mean progression free survival was 11 months (95% CI: 7–15). The weighted-mean overall survival was 22 months (95% CI 20–23 months) and 8 months (95% CI 1–32 months) for MA IRE and IRE alone, respectively. Early non-randomised data suggest MA IRE during pancreatic surgery for stage III pancreatic cancer may result in increased R0 resection rates and improved OS with acceptable postoperative morbidity. Further, larger studies are warranted to corroborate this evidence. |
format | Online Article Text |
id | pubmed-8268790 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-82687902021-07-10 Margin Accentuation Irreversible Electroporation in Stage III Pancreatic Cancer: A Systematic Review Ratnayake, Bathiya Al-Leswas, Dhya Mohammadi-Zaniani, Ghazaleh Littler, Peter Sen, Gourab Manas, Derek Pandanaboyana, Sanjay Cancers (Basel) Systematic Review SIMPLE SUMMARY: This literature review shows preliminary evidence to suggest that electroporation, the use of electricity to cause the death of cells around the tumour, may be associated with an improved survival and complete resection rates following pancreatic surgery for higher stage pancreatic cancer. However, one in five patients have a complication from the procedure that alters their normal course in hospital. Moreover, the number of patients who underwent this technique is small and further data is needed to support the preliminary evidence. The results therefore should be interpreted with caution. ABSTRACT: The present systematic review aimed to summarise the available evidence on indications and oncological outcomes after MA IRE for stage III pancreatic cancer (PC). A literature search was performed in the Pubmed, MEDLINE, EMBASE, SCOPUS databases using the PRISMA framework to identify all MA IRE studies. Nine studies with 235 locally advanced (LA) (82%, 192/235) or Borderline resectable (BR) PC (18%, 43/235) patients undergoing MA IRE pancreatic resection were included. Patients were mostly male (56%) with a weighted-mean age of 61 years (95% CI: 58–64). Pancreatoduodenectomy was performed in 51% (120/235) and distal pancreatectomy in 49% (115/235). R0 resection rate was 73% (77/105). Clavien Dindo grade 3–5 postoperative complications occurred in 19% (36/187). Follow-up intervals ranged from 3 to 29 months. Local and systematic recurrences were noted in 8 and 43 patients, respectively. The weighted-mean progression free survival was 11 months (95% CI: 7–15). The weighted-mean overall survival was 22 months (95% CI 20–23 months) and 8 months (95% CI 1–32 months) for MA IRE and IRE alone, respectively. Early non-randomised data suggest MA IRE during pancreatic surgery for stage III pancreatic cancer may result in increased R0 resection rates and improved OS with acceptable postoperative morbidity. Further, larger studies are warranted to corroborate this evidence. MDPI 2021-06-27 /pmc/articles/PMC8268790/ /pubmed/34199031 http://dx.doi.org/10.3390/cancers13133212 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Systematic Review Ratnayake, Bathiya Al-Leswas, Dhya Mohammadi-Zaniani, Ghazaleh Littler, Peter Sen, Gourab Manas, Derek Pandanaboyana, Sanjay Margin Accentuation Irreversible Electroporation in Stage III Pancreatic Cancer: A Systematic Review |
title | Margin Accentuation Irreversible Electroporation in Stage III Pancreatic Cancer: A Systematic Review |
title_full | Margin Accentuation Irreversible Electroporation in Stage III Pancreatic Cancer: A Systematic Review |
title_fullStr | Margin Accentuation Irreversible Electroporation in Stage III Pancreatic Cancer: A Systematic Review |
title_full_unstemmed | Margin Accentuation Irreversible Electroporation in Stage III Pancreatic Cancer: A Systematic Review |
title_short | Margin Accentuation Irreversible Electroporation in Stage III Pancreatic Cancer: A Systematic Review |
title_sort | margin accentuation irreversible electroporation in stage iii pancreatic cancer: a systematic review |
topic | Systematic Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268790/ https://www.ncbi.nlm.nih.gov/pubmed/34199031 http://dx.doi.org/10.3390/cancers13133212 |
work_keys_str_mv | AT ratnayakebathiya marginaccentuationirreversibleelectroporationinstageiiipancreaticcancerasystematicreview AT alleswasdhya marginaccentuationirreversibleelectroporationinstageiiipancreaticcancerasystematicreview AT mohammadizanianighazaleh marginaccentuationirreversibleelectroporationinstageiiipancreaticcancerasystematicreview AT littlerpeter marginaccentuationirreversibleelectroporationinstageiiipancreaticcancerasystematicreview AT sengourab marginaccentuationirreversibleelectroporationinstageiiipancreaticcancerasystematicreview AT manasderek marginaccentuationirreversibleelectroporationinstageiiipancreaticcancerasystematicreview AT pandanaboyanasanjay marginaccentuationirreversibleelectroporationinstageiiipancreaticcancerasystematicreview |